Rotonium will participate as a speaker at the conference “Quantum Computing in Life Sciences”, taking place in Milan on 16 April 2026. The event will explore the practical impact of quantum computing on the future pharmaceutical industry, spanning key themes such as R&D for new molecules and drugs, the adoption of AI and Digital Twins for personalized therapy simulations, the digitalization of pharma production, and the acceleration of time-to-market in increasingly dynamic market scenarios.
With quantum computing now entering strategic roadmaps and attracting significant industrial investment—especially through synergies with AI and Machine Learning—the conference will bring together experts from medicine, pharma companies, academia, data science, quantum platform providers, quantum-AI developers, policy makers, venture capital, and consulting to outline the state of the art and emerging scenarios, partnerships, and patient benefits.
During the program, Roberto Siagri (CEO, Rotonium) will deliver a talk on the advantages of photonic quantum accelerators for molecule development and genome analysis, highlighting compact, room-temperature solutions designed for integration into hybrid computing workflows—from industrial workstations to scaling toward private data centers.
